Jeffrey Jacot, PhD, who oversees the Jacot Lab for Pediatric Regenerative Medicine, easily gets pumped about his work.
Related Articles
News
Residential Care Increases Social Participation But Gaps Remain
August 4, 2025
UCBN
News, Syndication
Comments Off on Residential Care Increases Social Participation But Gaps Remain
A new study from the University of Colorado Anschutz Medical Campus finds that older adults become more socially active after moving into long-term care communities like nursing homes or assisted living facilities but we might […]
News
DeFloria Receives Investigational New Drug Application Clearance from FDA for Phase 2 Clinical Trial of AJA001, an Oral Cannabinoid Drug Being Developed for the Treatment of Autism Spectrum Disorder (ASD)
February 24, 2025
UCBN
News, Syndication
Comments Off on DeFloria Receives Investigational New Drug Application Clearance from FDA for Phase 2 Clinical Trial of AJA001, an Oral Cannabinoid Drug Being Developed for the Treatment of Autism Spectrum Disorder (ASD)
DeFloria plans to initiate a Phase 2 clinical trial by mid-year 2025 LITTLETON, Colo., Feb. 24, 2025 /PRNewswire/ — DeFloria, Inc., a collaboration between Ajna BioSciences PBC and Charlotte’s Web Holdings, Inc. (TSX: CWEB, OTCQX: […]
News
FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
April 4, 2024
UCBN
News, Syndication
Comments Off on FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Pictured: A scientist works behind an FDA sign/Taylor Tieden for BioSpace The FDA approved 55 new drugs and 34 cell and gene therapies in 2023. But it’s not always good news that companies have to deliver […]
